Motor neuron disease: Nusinersen potentially effective in SMA
- PMID: 28009016
- DOI: 10.1038/nrneurol.2016.199
Motor neuron disease: Nusinersen potentially effective in SMA
Comment on
-
Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study.Lancet. 2016 Dec 17;388(10063):3017-3026. doi: 10.1016/S0140-6736(16)31408-8. Epub 2016 Dec 7. Lancet. 2016. PMID: 27939059 Clinical Trial.
References
-
- Lancet. 2017 Dec 17;388(10063):3017-3026 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical